Richard B. Markham

3.3k total citations
85 papers, 2.7k citations indexed

About

Richard B. Markham is a scholar working on Immunology, Virology and Infectious Diseases. According to data from OpenAlex, Richard B. Markham has authored 85 papers receiving a total of 2.7k indexed citations (citations by other indexed papers that have themselves been cited), including 43 papers in Immunology, 33 papers in Virology and 30 papers in Infectious Diseases. Recurrent topics in Richard B. Markham's work include HIV Research and Treatment (33 papers), HIV/AIDS drug development and treatment (18 papers) and Immunotherapy and Immune Responses (14 papers). Richard B. Markham is often cited by papers focused on HIV Research and Treatment (33 papers), HIV/AIDS drug development and treatment (18 papers) and Immunotherapy and Immune Responses (14 papers). Richard B. Markham collaborates with scholars based in United States, China and Australia. Richard B. Markham's co-authors include Gerald B. Pier, David Vlahov, Homayoon Farzadegan, Joseph B. Margolick, Kristen V. Khanna, Cynthia M. Lyles, Donald R. Hoover, Jacqueline Astemborski, Thomas C. Quinn and Dennis L. Christie and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Lancet and Journal of Clinical Investigation.

In The Last Decade

Richard B. Markham

84 papers receiving 2.6k citations

Peers

Richard B. Markham
Hakim Hocini France
T. Blake Ball Canada
Steve Kaye United Kingdom
Mark Pandori United States
Miguel E. Quiñones‐Mateu United States
Roberto F. Speck Switzerland
Frances K. Newman United States
Daniel Boden United States
Bob van Gemen Netherlands
Kenneth L. Rosenthal Canada
Hakim Hocini France
Richard B. Markham
Citations per year, relative to Richard B. Markham Richard B. Markham (= 1×) peers Hakim Hocini

Countries citing papers authored by Richard B. Markham

Since Specialization
Citations

This map shows the geographic impact of Richard B. Markham's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Richard B. Markham with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Richard B. Markham more than expected).

Fields of papers citing papers by Richard B. Markham

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Richard B. Markham. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Richard B. Markham. The network helps show where Richard B. Markham may publish in the future.

Co-authorship network of co-authors of Richard B. Markham

This figure shows the co-authorship network connecting the top 25 collaborators of Richard B. Markham. A scholar is included among the top collaborators of Richard B. Markham based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Richard B. Markham. Richard B. Markham is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gordy, James T., Kun Luo, Samuel K. Ayeh, et al.. (2023). IFNα and 5-Aza-2’-deoxycytidine combined with a dendritic-cell targeting DNA vaccine alter tumor immune cell infiltration in the B16F10 melanoma model. Frontiers in Immunology. 13. 1074644–1074644. 10 indexed citations
2.
Chuang, Yu-Min, Noton K. Dutta, James T. Gordy, et al.. (2020). Antibiotic Treatment Shapes the Antigenic Environment During Chronic TB Infection, Offering Novel Targets for Therapeutic Vaccination. Frontiers in Immunology. 11. 680–680. 10 indexed citations
3.
Luo, Kun, Fidel Zavala, James T. Gordy, Hong Zhang, & Richard B. Markham. (2017). Extended protection capabilities of an immature dendritic-cell targeting malaria sporozoite vaccine. Vaccine. 35(18). 2358–2364. 9 indexed citations
4.
Zhang, Nannan, Haoran Guo, Guanchen Liu, et al.. (2017). The poly-proline tail of SIVmac Vpx provides gain of function for resistance to a cryptic proteasome-dependent degradation pathway. Virology. 511. 23–29. 1 indexed citations
5.
Liu, Xianjun, Haoran Guo, Hong Wang, et al.. (2015). HIV-1 Vpr suppresses the cytomegalovirus promoter in a CRL4(DCAF1) E3 ligase independent manner. Biochemical and Biophysical Research Communications. 459(2). 214–219. 2 indexed citations
6.
Wei, Wei, Haoran Guo, Jingliang Li, et al.. (2014). Circulating HFMD-Associated Coxsackievirus A16 Is Genetically and Phenotypically Distinct from the Prototype CV-A16. PLoS ONE. 9(4). e94746–e94746. 21 indexed citations
7.
8.
Olmsted, Stuart S., Kristen V. Khanna, Steven T. Whitten, et al.. (2005). Low pH immobilizes and kills human leukocytes and prevents transmission of cell-associated HIV in a mouse model. BMC Infectious Diseases. 5(1). 79–79. 45 indexed citations
9.
Neuveut, Christine, et al.. (2003). Requirement for the Second Coding Exon of Tat in the Optimal Replication of Macrophage-Tropic HIV-1. Journal of Biomedical Science. 10(6). 651–660. 21 indexed citations
10.
Neuveut, Christine, et al.. (2003). Requirement for the second coding exon of Tat in the optimal replication of macrophage-tropic HIV-1. Journal of Biomedical Science. 10(6). 651–660. 17 indexed citations
11.
Khanna, Kristen V., Kevin J. Whaley, Larry Zeitlin, et al.. (2002). Vaginal transmission of cell-associated HIV-1 in the mouse is blocked by a topical, membrane-modifying agent. Journal of Clinical Investigation. 109(2). 205–211. 107 indexed citations
12.
Khanna, Kristen V., Kevin J. Whaley, Larry Zeitlin, et al.. (2002). Vaginal transmission of cell-associated HIV-1 in the mouse is blocked by a topical, membrane-modifying agent. Journal of Clinical Investigation. 109(2). 205–211. 5 indexed citations
13.
Khanna, Kristen V., et al.. (2000). Differences Among HIV-1 Variants in Their Ability to Elicit Secretion of TNF-α. The Journal of Immunology. 164(3). 1408–1415. 27 indexed citations
14.
Carneiro, Mariângela, Xiao‐Fang Yu, Cynthia M. Lyles, et al.. (1999). The Effect of Drug‐Injection Behavior on Genetic Evolution of HIV‐1. The Journal of Infectious Diseases. 180(4). 1025–1032. 9 indexed citations
15.
Khanna, Kristen V. & Richard B. Markham. (1999). A Perspective on Cellular Immunity in the Elderly. Clinical Infectious Diseases. 28(4). 710–713. 28 indexed citations
16.
Wang, Zhe, Cynthia M. Lyles, Chris Beyrer, et al.. (1998). Diversification of Subtype E Human Immunodeficiency Virus Type 1envin Heterosexual Seroconverters from Northern Thailand. The Journal of Infectious Diseases. 178(5). 1507–1511. 25 indexed citations
17.
Farzadegan, Homayoon, Donald R. Hoover, Jacqueline Astemborski, et al.. (1998). Sex differences in HIV-1 viral load and progression to AIDS. The Lancet. 352(9139). 1510–1514. 334 indexed citations
18.
Markham, Richard B., Xinyao Yu, Homayoon Farzadegan, Stuart C. Ray, & David Vlahov. (1995). Human Immunodeficiency Virus Type 1 env and p17gag Sequence Variation in Polymerase Chain Reaction-Positive, Seronegative Injection Drug Users. The Journal of Infectious Diseases. 171(4). 797–804. 13 indexed citations
19.
Markham, Richard B., N. A. Halsey, Jacqueline Coberly, et al.. (1994). Maternal IgG1 and IgA antibody to V3 loop consensus sequence and maternal-infant HIV-1 transmission. The Lancet. 343(8894). 390–391. 23 indexed citations
20.
Markham, Richard B., Philip W. Stashak, Benjamin Prescott, Diana F. Amsbaugh, & Phillip J. Baker. (1977). Effect of concanavalin A on lymphocyte interactions involved in the antibody response to type III pneumococcal polysaccharide I. Comparison of the suppression induced by con A and low dose paralysis.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 118(3). 952–6. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hakim Hocini Breakdown of academic impact, for papers by T. Blake Ball Breakdown of academic impact, for papers by Steve Kaye Breakdown of academic impact, for papers by Mark Pandori Breakdown of academic impact, for papers by Miguel E. Quiñones‐Mateu Breakdown of academic impact, for papers by Roberto F. Speck Breakdown of academic impact, for papers by Frances K. Newman Breakdown of academic impact, for papers by Daniel Boden Breakdown of academic impact, for papers by Bob van Gemen Breakdown of academic impact, for papers by Kenneth L. Rosenthal
Rankless by CCL
2026